ZPD A/S: Financial statements 2024
CVR: 32834825
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ZPD A/S (CVR 32834825) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 49,315,000 and a net result of DKK 12,864,000 compared with DKK 11,824,000 the year before. That is an increase of 12.6% compared with the year before. Equity in the 2024 report amounted to DKK 208,920,000. The solvency ratio was 94.5%. The company had 35 employees in the financial year.
- Gross Profit
- DKK 49,315,000
- Profit/Loss
- DKK 12,864,000
- Equity
- DKK 208,920,000
- Total Assets
- DKK 221,038,000
- Employees
- 35
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 49.3 mio. | 12.9 mio. | 208.9 mio. | 35 |
| 2023 | - | 43.8 mio. | 11.8 mio. | 197.1 mio. | 35 |
| 2022 | - | 37.3 mio. | 7.1 mio. | 185.2 mio. | 35 |
| 2021 | - | 35.2 mio. | 7 mio. | 178.2 mio. | 36 |
| 2020 | - | 35.6 mio. | 6 mio. | 171.2 mio. | 34 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ZPD A/S has published its annual report for 2023. Gross profit came to DKK 43,788,000, and the net result was DKK 11,824,000.
About ZPD A/S
ZPD A/S is a Danish company of the type Aktieselskab based in Esbjerg, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named BIOFAC ESBJERG A/S. The management consists of Frank Marek and Hiroyuki Shinya. The board consists of Masakazu Sakurai (chair), Frank Marek and Ken Motegi. The company is owned by Zeria Pharmaceutical Co. Ltd.. The company has 54 employees (2026). In 2025, the company reported a gross profit of DKK 52,704,000 and a net result of DKK 10,220,000 compared with DKK 12,864,000 the year before. Equity in the 2025 report amounted to DKK 217,641,000.